EFFECT OF TENOFOVIR ALAFENAMIDE FUMARATE (TAF) PROPHYLAXIS FOR HEPATITIS B VIRUS REACTIVATION IN HBV-INFECTED INDIVIDUALS, WHO RECEIVED CHEMO/IMMUNOSUPPRESSIVE THERAPY


Yapalı S.

AASLD_TASL Digital Hepatology Connect, 15 - 16 January 2021, pp.3-4

  • Publication Type: Conference Paper / Full Text
  • Page Numbers: pp.3-4